| 000 | 01619 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512024811.0 | ||
| 264 | 0 | _c19890504 | |
| 008 | 198905s 0 0 jpn d | ||
| 022 | _a0021-4949 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaba, S | |
| 245 | 0 | 0 |
_a[Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report]. _h[electronic resource] |
| 260 |
_bGan no rinsho. Japan journal of cancer clinics _cFeb 1989 |
||
| 300 |
_a371-7 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlopecia _xchemically induced |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aUterine Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aKashimura, M | |
| 700 | 1 | _aShinohara, M | |
| 700 | 1 | _aKusano, S | |
| 700 | 1 | _aSasayama, T | |
| 700 | 1 | _aHamasaki, K | |
| 773 | 0 |
_tGan no rinsho. Japan journal of cancer clinics _gvol. 35 _gno. 3 _gp. 371-7 |
|
| 999 |
_c2932825 _d2932825 |
||